Furthermore, violacein significantly suppressed the proliferation and formation of tumorspheres of HCC stem-like cells by reducing the expression of HCC stemness markers, including CD133, Sox2, Oct4, and Nanog, and by inhibiting the STAT3/AKT/ERK signaling pathways. The gene discussed is MAPK1; the disease is hepatocellular carcinoma.